Catalyst Pharmaceuticals Inc (CPRX)

Payables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	78,189	81,414	76,304	63,600	61,026	47,353	42,851	38,449	34,393	30,546	26,191	23,093	21,884	19,406	17,975	17,570	17,040	16,568	17,076	17,198
Payables	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Payables turnover		—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $78,189K ÷ $—K
= —

Based on the provided data, Catalyst Pharmaceuticals Inc's payables turnover ratio is not available or not provided for the period from March 31, 2020, to December 31, 2024. The absence of information on payables turnover limits the analysis of the company's efficiency in managing its trade payables.

It is important to note that the payables turnover ratio is a key financial metric that indicates how efficiently a company is managing its accounts payable by paying off suppliers and vendors. A higher turnover ratio generally indicates that the company is paying off its payables more quickly.

Without the specific numerical values for the payables turnover ratio for Catalyst Pharmaceuticals Inc, it is challenging to assess the company's payment practices, liquidity, and relationships with its suppliers during the specified period. Additional financial data or context would be needed to conduct a more in-depth analysis of the company's payables turnover and its implications for the overall financial health of the organization.